172 related articles for article (PubMed ID: 33658218)
21. Storage of alpha-1-antitrypsin in intrahepatic bile duct cells in alpha-1-antitrypsin deficiency (Pi Z phenotype).
Callea F; Fevery J; Massi G; de Groote J; Desmet VJ
Histopathology; 1985 Jan; 9(1):99-108. PubMed ID: 2984102
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism.
Milger K; Holdt LM; Teupser D; Huber RM; Behr J; Kneidinger N
Int J Chron Obstruct Pulmon Dis; 2015; 10():891-7. PubMed ID: 26005342
[TBL] [Abstract][Full Text] [Related]
23. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
[TBL] [Abstract][Full Text] [Related]
24. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
25. In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.
Cruz PE; Mueller C; Cossette TL; Golant A; Tang Q; Beattie SG; Brantly M; Campbell-Thompson M; Blomenkamp KS; Teckman JH; Flotte TR
Lab Invest; 2007 Sep; 87(9):893-902. PubMed ID: 17592477
[TBL] [Abstract][Full Text] [Related]
26. Disease Status at Diagnosis in Danish Children with α 1 -antitrypsin Deficiency.
Winther CL; Nyrann S; Nielsen RG; Duno M; Johansen KB; Helt TW; Brix Christensen V
J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):629-634. PubMed ID: 36070551
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of children with α-1 antitrypsin deficiency.
Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
[TBL] [Abstract][Full Text] [Related]
28. alpha1-Antitrypsin deficiency: best clinical practice.
Kalsheker NA
J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
[TBL] [Abstract][Full Text] [Related]
29. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
30. Alpha-1-antitrypsin deficiency.
Bals R
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
[TBL] [Abstract][Full Text] [Related]
31. The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients.
Sark AD; Fromme M; Olejnicka B; Welte T; Strnad P; Janciauskiene S; Stolk J
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327571
[TBL] [Abstract][Full Text] [Related]
32. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
[TBL] [Abstract][Full Text] [Related]
33. Advances in alpha-1-antitrypsin deficiency liver disease.
Teckman JH; Jain A
Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
[TBL] [Abstract][Full Text] [Related]
34. Challenging identification of a novel PiISF and the rare PiMmaltonZ α1-antitrypsin deficiency variants in two patients.
Suh-Lailam BB; Procter M; Krautscheid P; Haas J; Kumar S; Mao R; Grenache DG
Am J Clin Pathol; 2014 May; 141(5):742-6. PubMed ID: 24713750
[TBL] [Abstract][Full Text] [Related]
35. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
Zuo L; Pannell BK; Zhou T; Chuang CC
Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
[TBL] [Abstract][Full Text] [Related]
36. Increased Prevalence of Alpha-1-Antitrypsin Deficiency in Patients with Biliary Tract Cancer and Its Associated Clinicopathological Features.
Cornillet M; Zemack H; Jansson H; Sparrelid E; Ellis E; Björkström NK
Cells; 2023 Jun; 12(12):. PubMed ID: 37371133
[TBL] [Abstract][Full Text] [Related]
37. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
Wooddell CI; Blomenkamp K; Peterson RM; Subbotin VM; Schwabe C; Hamilton J; Chu Q; Christianson DR; Hegge JO; Kolbe J; Hamilton HL; Branca-Afrazi MF; Given BD; Lewis DL; Gane E; Kanner SB; Teckman JH
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32379724
[TBL] [Abstract][Full Text] [Related]
38. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
Francalanci P; Santorelli FM; Saccani S; Bonetti MF; Medicina D; Coni P; Faa G; Callea F
Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
[TBL] [Abstract][Full Text] [Related]
39. Fazirsiran for Liver Disease Associated with Alpha
Strnad P; Mandorfer M; Choudhury G; Griffiths W; Trautwein C; Loomba R; Schluep T; Chang T; Yi M; Given BD; Hamilton JC; San Martin J; Teckman JH
N Engl J Med; 2022 Aug; 387(6):514-524. PubMed ID: 35748699
[TBL] [Abstract][Full Text] [Related]
40. [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease].
Burbaum B; Fromme M; Strnad P
Dtsch Med Wochenschr; 2021 Jun; 146(11):714-718. PubMed ID: 34062584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
